Katharina J. Wenger

ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma

Marlies Wagner, Nina von Mettenheim, Patrick N. Harter et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 86 citations

Neuro-oncology, Radiation Oncology, Chemoprevention Strategy +10

Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors

Antje Wick, Oliver Bähr, Martin Schüler et al. · Clinical Cancer Research · 2021 · 64 citations · Full text

Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine

Katharina J. Wenger, Marlies Wagner, Se-Jong You et al. · Oncology Letters · 2017 · 63 citations · Full text

Neuro-oncology, Pfs Rate, Oncology +14

Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial

Katharina J. Wenger, Nina von Mettenheim, Jörg Bojunga et al. · European Journal of Nutrition · 2021 · 52 citations · Full text

Intracellular pH measured by ³¹P‐MR‐spectroscopy might predict site of progression in recurrent glioblastoma under antiangiogenic therapy

Katharina J. Wenger, Elke Hattingen, Kea Franz et al. · Journal of Magnetic Resonance Imaging · 2017 · 44 citations · Full text